Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 30 ... A larger dose of angiotensin receptor blockers (ARBs) is more effective than a smaller dose in heart failure ... of Low-Dose vs. High-Dose Losartan Treatment on Morbidity and Mortality in Angiotensin-ConvertingEnzyme Inhibitor-Intolerant Patients with Heart Failure and Reduced Left Ventricular ...
2009 NOV 30 ... sPLA2 activity test was used in 3778 patients in the PEACE (Prevention of Events with Angiotensin Converting Enzyme Inhibition) trial and the results were presented at the American Heart Association's ...
2009 NOV 23 ... from Takamatsu, Japan, "Recent studies indicate a role of chymase in the regulation of angiotensin II (AngII) formation in cardiovascular and renal tissues. We investigated a possible ... mRNA level in the obstructed kidney than sham-operated ones. In contrast, angiotensin-convertingenzyme (ACE) protein expression was significantly lower in UUO hamsters. In UUO ...
2009 NOV 30 ... early feedback group after the public release of the report card. "The absolute rate of angiotensin-convertingenzyme (ACE) inhibitor and angiotensin II receptor blocker use in patients ...
2009 NOV 23 ... "Combination therapy with angiotensin II Type I receptor blocker 50 mg of losartan and a fixed combination of losartan (50 ... its renoprotective effect. Subjects already being administered the angiotensin I-convertingenzyme inhibitor enalapril and losartan 100 mg daily were enrolled in this open-labeled ...
2009 DEC 5 ... "The role of the apoliprotein E (APOE) and the angiotensin converting enzyme (ACE) polymorphisms on health and functional status deterioration in old age is still ...
2009 NOV 30 ... of days that medications were taken correctly (diuretics: r = 0.173, P< .05, and angiotensin-convertingenzyme: r = 0.223, P = .01). Finally, patients seeking emergency care or ...
2009 NOV 30 ... provides additional prognostic information is not known." "Renin-angiotensin blockade medications improve outcomes in HF but are underutilized in HF patients with ... Disease, and the Effect of an Angiotensin Receptor Blocker in Addition to an Angiotensin-ConvertingEnzyme Inhibitor in Patients With Moderate to Severe Heart Failure. Circulation, ...
2009 NOV 23 ... and more likely to have a nonischemic etiology and a higher ejection fraction. Dose of angiotensin converting enzyme inhibitor (ACEI) was lower in the women, on average. The lower ACEI dose may reflect the ...
2009 NOV 30 ... The mean age of the patients was 80 +/- 7.8 years; 46% were male; 64% were receiving an angiotensin-convertingenzyme inhibitor, 34% an angiotensin-II receptor blocker, and 68% were ...
2009 NOV 30 ... of sardine protein (sardine peptide, SP) derived from sardine muscle possesses angiotensin I-convertingenzyme (ACE) inhibitory activity. In the present study, we investigated the ...
2009 NOV 23 ... diabetes, smoking, body mass index (BMI), fasting cholesterol, fasting glucose, angiotensin-converting-enzyme inhibitors, beta-blockers, statins, and antidepressants). HRV ...
2009 NOV 30 ... an anti hypertensive effect in spontaneously hypertensive rats (SHRs). We isolated an angiotensin I-convertingenzyme (ACE) inhibitory peptide, Gly-Phe-Hyp-Gly-Pro (IC50 = 91 mc M), from ...
2009 NOV 30 ... "The renin-angiotensin system (RAS) is involved in cell growth, proliferation and differentiation in bone ... to assess expressions of the RAS components, renin, angiotensinogen and angiotensin-convertingenzyme (ACE), during imatinib mesylate treatment of patients with chronic myeloid ...
2009 NOV 30 ... has been documented many times and correlates with prognosis. The influence of the renin-angiotensin-aldosterone system (RAAS) on endothelial dysfunction has also been studied." ... receptor blocker (ARB; irbesartan 300 mg/day or valsartan 160 mg/day) or an angiotensin-convertingenzyme inhibitor (ACEi; fosinopril 10 mg/day or quinapril 20 mg/day). If target blood ...
2009 NOV 30 ... P = 89.0%) (mean baseline systolic BP similar to 130 mmHg) and >50% were receiving an angiotensin-convertingenzyme inhibitor and/or beta-blocker (V = 57.4%, P = 54.9%). The mean ...
2009 NOV 30 ... "Peanut hydrolysate obtained after 6 h of digestion by Alcalase was used to isolate angiotensin I convertingenzyme (ACE) inhibitory peptides. After centrifugation and ultrafiltration ...
2009 NOV 23 ... increasing blood pressure. Suppression of the renin angiotensin system using angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blocker (ARB) drug therapies has been shown to ...
